THIOCTIC ACID
1,2-Dithiolane-3-pentanoic acid, (+/-)-
THIOCTIC ACID figure dans l’inventaire CosIng de l’UE, mais aucune fiche d’annexe directe n’est encore associée sur cette page.
En un coup d’œil
- Fonction
- Antioxidant
- CAS
- 1077-28-7
- EC
- 214-071-2
- Annexes de l’UE
- Non répertoriéAucune fiche d’annexe de l’UE n’est associée. Ce n’est pas une autorisation.
Preuves réglementaires par marché
Cette matrice distingue les règles d’ingrédients vérifiées des sources cartographiées mais pas encore importées. L’absence de règle importée ne signifie pas que l’ingrédient est autorisé.
Balayez ou faites défiler horizontalement pour voir toutes les colonnes.
| Marché | Statut des preuves | Fiches | Langue de la source |
|---|---|---|---|
| European Union | Source cartographiée Inventory entry; no linked annex rule | 0 | English and EU languages |
| Great Britain | Source cartographiée Official source mapped; ingredient rule not imported | 0 | English |
| Canada | Source cartographiée Official source mapped; ingredient rule not imported | 0 | English and French |
| New Zealand | Source cartographiée Official source mapped; ingredient rule not imported | 0 | English |
| ASEAN | Source cartographiée Official source mapped; ingredient rule not imported | 0 | English and national languages |
| China | Source cartographiée Official source mapped; ingredient rule not imported | 0 | Chinese with selected English material |
| Japan | Preuves associées Restricted Ouvrir cette preuve | 1 | Japanese; official English translation available |
| South Korea | Source cartographiée Official source mapped; ingredient rule not imported | 0 | Korean with some English names |
| United States | Source cartographiée Official source mapped; ingredient rule not imported | 0 | English |
| Australia | Source cartographiée Official source mapped; ingredient rule not imported | 0 | English |
| Brazil | Source cartographiée Official source mapped; ingredient rule not imported | 0 | Portuguese with INCI crosswalks |
| India | Source cartographiée Official source mapped; ingredient rule not imported | 0 | English and Hindi |
| Saudi Arabia | Source cartographiée Official source mapped; ingredient rule not imported | 0 | Arabic and English |
Détails d’inventaire pour THIOCTIC ACID
Nom INCI
THIOCTIC ACID
Nom DCI
Thioctic acid [JAN]
Description
1,2-Dithiolane-3-pentanoic acid, (+/-)-
Provenance de la fiche
- Référence d’inventaire
- 60299
- Identité importée
- THIOCTIC ACID
- Mise à jour de la source
- 15/10/2010
Fiches d’annexe pour THIOCTIC ACID
Données clés
- ANTIOXIDANT
Inhibiting reactions promoted by oxygen, thus avoiding oxidation and rancidity.
Identité et propriétés chimiques

alpha Lipoic acid
Lipoic acid is a heterocyclic thia fatty acid comprising pentanoic acid with a 1,2-dithiolan-3-yl group at the 5-position. It has a role as a geroprotector and a fundamental metabolite. It is a member of dithiolanes, a heterocyclic fatty acid and a thia fatty acid. It is functionally related to an octanoic acid. It is a conjugate acid of a lipoate. — ChEBI
- Nom IUPAC
- 5-(dithiolan-3-yl)pentanoic acid
- Formule moléculaire
- C8H14O2S2
- Masse moléculaire
- 206.3 g/mol
- Masse exacte
- 206.04352203 Da
- XLogP3
- 1,7
- Surface polaire topologique
- 87,9 Ų
- Donneurs de liaisons hydrogène
- 1
- Accepteurs de liaisons hydrogène
- 4
- Unités covalentes
- 1
- Stéréocentres définis
- 0
Également connu sous le nom de
16 autres noms signalés
Identifiants de bases de données externes
- ChEBI:CHEBI:16494
- ChEMBL:CHEMBL33864
- EPA DTXSID:DTXSID7025508
- PubMed:22654724
- PubMed:22448096
- PubMed:22384101
- PubMed:22374556
- PubMed:22363901
- PubMed:22272085
- PubMed:22242957
- PubMed:22163871
- PubMed:22163517
- PubMed:22146387
- PubMed:22125679
- PubMed:22125537
Preuves issues de bases de données scientifiques complémentaires
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- Color/Form: Forms yellowish flakes Source: Hazardous Substances Data Bank (HSDB)
- Dissociation Constants: pKa = 5.10 Source: Hazardous Substances Data Bank (HSDB)
- Melting Point: 47.5-48 °C Source: Hazardous Substances Data Bank (HSDB)
- Solubility: Yellow powder; solubility in ethanol: 50 mg/mL /Synthetic, oxidized form/ Source: Hazardous Substances Data Bank (HSDB)
- Solubility: Soluble in methanol, ethanol, diethyl ether and chloroform Source: Hazardous Substances Data Bank (HSDB)
- Carcinogen Classification: No indication of carcinogenicity to humans (not listed by IARC). Source: Toxin and Toxin Target Database (T3DB)
- Note: This chemical does not meet GHS hazard criteria for 6.5% (28 of 430) of reports. Source: European Chemicals Agency (ECHA)
- Signal: Warning Source: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H302 (93.5%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (48.6%): Causes skin irritation [Warning Skin corrosion/irritation]; H317 (46.5%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H319 (47%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H411 (46.5%): Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard] Source: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P261, P264, P264+P265, P270, P272, P273, P280, P301+P317, P302+P352, P305+P351+P338, P321, P330, P332+P317, P333+P317, P337+P317, P362+P364, P391, and P501 (click each P-code to see the statement) Source: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 430 reports by companies from 16 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 28 of 430 reports by companies.; There are 14 notifications provided by 402 of 430 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
- Note: This chemical does not meet GHS hazard criteria for 42.3% (52 of 123) of reports. Source: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H302 (57.7%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (31.7%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (31.7%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335 (31.7%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]; H412 (19.5%): Harmful to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard] Source: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P261, P264, P264+P265, P270, P271, P273, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement) Source: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 123 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 52 of 123 reports by companies.; There are 7 notifications provided by 71 of 123 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
- Health Effects: Acute exposure to cholinesterase inhibitors can cause a cholinergic crisis characterized by severe nausea/vomiting, salivation, sweating, bradycardia, hypotension, collapse, and convulsions. Increasing muscle weakness is a possibility and may result in death if respiratory muscles are involved. Accumulation of ACh at motor nerves causes overstimulation of nicotinic expression at the neuromuscular junction. When this occurs symptoms such as muscle weakness, fatigue, muscle cramps, fasciculation, and paralysis can be seen. When there is an accumulation of ACh at autonomic ganglia this causes overstimulation of nicotinic expression in the sympathetic system. Symptoms associated with this are hypertension, and hypoglycemia. Overstimulation of nicotinic acetylcholine receptors in the central nervous system, due to accumulation of ACh, results in anxiety, headache, convulsions, ataxia, depression of respiration and circulation, tremor, general weakness, and potentially coma. When there is expression of muscarinic overstimulation due to excess acetylcholine at muscarinic acetylcholine receptors symptoms of visual disturbances, tightness in chest, wheezing due to bronchoconstriction, incre Source: Toxin and Toxin Target Database (T3DB)
- Toxicity Summary: ALA is generally considered a safe drug. A daily dose of 200 mg/day to 2400 mg/day of ALA is deemed safe without significant adverse effects. However, there is no reported safe dose in children.; A notable case in literature demonstrated status epilepticus (SE) that subsided within a few days. The seizures were treated per normal standards for SE.; In the last 2 decades, there have been few reported cases of ALA toxicity in humans. Most of these cases occur in children and are treatable. Though there is no established lethal dosage of ALA for humans, studies have shown that a high dose of 121 mg/kg body weight/day was associated with alterations in liver enzymes and liver function. Therefore, there are potentially harmful adverse effects from overdosing on ALA, and more studies are necessary to determine the toxicity. Source: StatPearls
- Toxicity Summary: (R)-lipoic acid is a cholinesterase or acetylcholinesterase (AChE) inhibitor. A cholinesterase inhibitor (or 'anticholinesterase') suppresses the action of acetylcholinesterase. Because of its essential function, chemicals that interfere with the action of acetylcholinesterase are potent neurotoxins, causing excessive salivation and eye-watering in low doses, followed by muscle spasms and ultimately death. Nerve gases and many substances used in insecticides have been shown to act by binding a serine in the active site of acetylcholine esterase, inhibiting the enzyme completely. Acetylcholine esterase breaks down the neurotransmitter acetylcholine, which is released at nerve and muscle junctions, in order to allow the muscle or organ to relax. The result of acetylcholine esterase inhibition is that acetylcholine builds up and continues to act so that any nerve impulses are continually transmitted and muscle contractions do not stop. Among the most common acetylcholinesterase inhibitors are phosphorus-based compounds, which are designed to bind to the active site of the enzyme. The structural requirements are a phosphorus atom bearing two lipophilic groups, a leaving group (such as Source: Toxin and Toxin Target Database (T3DB)
- Uses: Nutrition, biochemical research /Thioctic acid, dl-form/ Source: Hazardous Substances Data Bank (HSDB)
- Uses: THERAPEUTIC CATEGORY: Treatment of liver disease; antidote to poisonous mushrooms (Amanita species). Source: Hazardous Substances Data Bank (HSDB)
- Uses: Use (kg; approx.) in Germany (2009): >7500; Consumption (g per capita; approx.) in Germany (2009): 0.0916; Calculated removal (%): 96.4 Source: NORMAN Suspect List Exchange
- Uses: For nutritional supplementation, also for treating dietary shortage or imbalance. Source: Toxin and Toxin Target Database (T3DB)
Mis en correspondance par: Existing checksum-valid CAS to unique PubChem CID match. Récupéré le: 2026-08-31. Ouvrir la fiche source
Les classifications scientifiques et les annotations de danger apportent du contexte et ne remplacent pas la décision réglementaire propre au marché indiquée ci-dessus.
Couverture des sources complémentaires et état des correspondances
| Source | Résultat | Vérifié |
|---|---|---|
| NIH PubChem PUG-View | Correspondance exacte | 2026-08-31 |
Une absence de correspondance enregistrée est une preuve utile que la source a été vérifiée ; ce n’est pas l’affirmation que la substance n’existe pas ailleurs.
Récupéré depuis NIH PubChem le 2026-09-02 par correspondance CAS à somme de contrôle valide. Les propriétés chimiques ne remplacent pas la décision réglementaire de cette page.
Preuves officielles sur le nom d’ingrédient de l’UE
Le nom de l’ingrédient correspond exactement au glossaire officiel 2025 de l’UE des dénominations communes d’ingrédients.
Preuves d’inventaire associées
Ingrédients ayant des fonctions de formulation communes
Sources officielles et scientifiques complémentaires
11 bases de données externes pour vérifier cette identité
Chaque lien lance une recherche de cette identité dans la source concernée. Ce qu’est chaque source et sa valeur juridique
Comment THIOCTIC ACID apparaît dans l’inventaire CosIng
L’inventaire CosIng répertorie THIOCTIC ACID comme ingrédient cosmétique et cette page l’associe à 0 fiche d’annexe. L’entrée d’inventaire reprend les noms et identifiants, tandis que la fiche d’annexe indique où la substance est interdite, soumise à restrictions ou inscrite sur une liste positive dans le droit de l’UE sur les cosmétiques.
THIOCTIC ACID est aussi associé à 1 fonction cosmétique dans les données officielles. Les désignations de fonction décrivent l’usage prévu, mais ne remplacent pas l’examen réglementaire des fiches d’annexe associées avant un travail de formulation ou d’étiquetage.
Questions fréquentes
Note de source pour THIOCTIC ACID
Cette page reproduit l’entrée d’inventaire CosIng de THIOCTIC ACID issue de documents publics de la Commission européenne sur les ingrédients cosmétiques et affiche les identifiants associés, même si aucune correspondance directe avec une annexe n’est actuellement rattachée.
Utilisez cette page d’inventaire pour étudier THIOCTIC ACID et comparer les fiches associées, mais vérifiez les restrictions et le statut juridique auprès du texte officiel en vigueur et de la législation avant toute décision réglementaire.
Outils et étapes suivantes
Vérifiez votre formule
Analysez une liste INCI complète pour détecter THIOCTIC ACID et les éventuelles restrictions d’annexes de l’UE ou signalements d’allergènes associés.
Vérificateur INCIRechercher des ingrédients similaires
Trouvez d’autres ingrédients de l’inventaire et entrées d’annexe liés à THIOCTIC ACID, à ses identifiants ou à des variantes de nom proches.
Rechercher